TESTBANK #
l
CALCULATING DRUG DOSAGES: l# l#
A Patient-Safe Approach to Nursing and Math
l# l# l# l# l# l#
2nd Edition
l#
Castillo | Werner-McCullough
l# l#
,TEST BANK
l#
,Castillo/Werner-McCullough: l#Calculating l#Drug l#Dosages: l#A l#Patient-Safe l#Approach l#to l#Nursing l#and
l#Math,,2e l # Test l#Bank
Table l#of l#Contents:
I. Safety l#in l#Medication l#Administration
l # Chapter l#1. l#Safety l#in l#Medication
l#Administration l # Chapter l#2. l#The l#Drug
l#Label
II. Systems l#of l#Measurement
l # Chapter l#3. l#The l#Metric
l#System l # Chapter l#4. l#The
l#Household l#System
III. Methods l#of l#Calculation
Chapter l#5. l#Linear l#Ratio l#and
l#Proportion l # Chapter l#6. l#Fractional
l#Ratio l#and l#Proportion l # Chapter l#7.
l#Dimensional l#Analysis
Chapter l#8. l#Formula l#Method
IV. Administration l#of l#Medications
Chapter l#9. l#Calculating l#Oral l#Medication
l#Doses l # Chapter l#10. l#Syringes l#and
l#Needles
Chapter l#11. l#Calculating l#Parenteral l#Medication
l#Dosages l # Chapter l#12. l#Preparing l#Powdered
l#Parenteral l#Medications l # Chapter l#13.
l#Administration l#of l#Insulin
V. IV l#Therapy l#and l#Administration l#of l#Intravenous l#Medications
Chapter l#14. l#Intravenous l#Infusion l#and l#Infusion
l#Rates l # Chapter l#15. l#Calculating l#Infusion l#and
l#Completion l#Time l # Chapter l#16. l#Administering
l#IV l#Push l#Medications
VI. Verifying l#Safe l#Dose l#and l#Critical l#Care l#Calculations
Chapter l#17. l#Verifying l#Safe l#Dose
Chapter l#18. l#Titration l#of l#Intravenous l#Medications
VII. Intake l#and l#Output
Chapter l#19. l#Calculating l#Intake l#and
l#Output l # Chapter l#20. l#Calculating
l#Parenteral l#Intake
VIII. Dosages l#for l#Pediatric l#and l#Older l#Adult l#Populations
Chapter l#21. l#Considerations l#for l#the l#Pediatric
l#Patient l # Chapter l#22. l#Considerations l#for l#the
l#Older l#Adult
, Castillo/Werner-McCullough: l#Calculating l#Drug l#Dosages,
l#2e
Chapter l#1: l#Safety l#in l#Medication l#Administration
Castillo: l#Calculating l#Drug l#Dosages: l#A l#Patient-Safe l#Approach l#to l#Nursing l#and l#Math
l#2nd l#Edition
MULTIPLE l#CHOICE
1. The l#following l#medication l#order l#is l#in l#the l#patient’s l#medication l#administration
l#record l#(MAR):
methylPREDnisolone l#40 l#mg l#PO l#daily l#at l#0900.
After l#reading l#the l#order, l#the l#nurse l#correctly
l#determines: l # A “PO” l#is l#an l#inappropriate
l#abbreviation.
B the l#medication l#order l#is l#written
l#correctly. l # C 40 l#mg l#should l#be l#written
l#as l#40mg.
D tall l#man l#lettering l#indicates l#that l#the l#drug l#is l#a l#narcotic.
ANS: l#B
Feedback
The l#medication l#order l#has l#all l#the l#required l#components l#(drug l#name,
l#dose, l#route, l#and l # frequency l#of l#administration) l#for l#a l#drug l#order.
l#“PO” l#is l#an l#appropriate l#abbreviation; l # 40 l#mg l#is l#written l#correctly
l#with l#a l#space l#between l#the l#dose l#and l#the l#unit l#of l # measurement. l#Tall
l#man l#lettering l#is l#used l#to l#distinguish l#the l#drug l#from l#another l#drug
l # with l#a l#similar l#name.
2. Which l#of l#the l#following l#accurately l#describes l#the l#“Boxed l#Warning” l#found
l#on l#a l#drug l#label? l # A It l#is l#primarily l#is l#used l#to l#identify l#the l#safe l#dose
l#for l#the l#patient.
B It l#is l#commonly l#found l#on l#all l#drug l#labels.
C It l#identifies l#serious l#potential l#risks l#and l#side l#effects l#related
l#to l#drug l#use. l # D It l#protects l#the l#patient l#by l#providing
l#information l#to l#decrease l#side l#effects.
ANS: l#C
Feedback
A l#drug l#label l#with l#a l#boxed l#warning l#provides l#information l#to
l#healthcare l#professionals l # and l#patients l#regarding l#the l#serious l#risks
1
l
CALCULATING DRUG DOSAGES: l# l#
A Patient-Safe Approach to Nursing and Math
l# l# l# l# l# l#
2nd Edition
l#
Castillo | Werner-McCullough
l# l#
,TEST BANK
l#
,Castillo/Werner-McCullough: l#Calculating l#Drug l#Dosages: l#A l#Patient-Safe l#Approach l#to l#Nursing l#and
l#Math,,2e l # Test l#Bank
Table l#of l#Contents:
I. Safety l#in l#Medication l#Administration
l # Chapter l#1. l#Safety l#in l#Medication
l#Administration l # Chapter l#2. l#The l#Drug
l#Label
II. Systems l#of l#Measurement
l # Chapter l#3. l#The l#Metric
l#System l # Chapter l#4. l#The
l#Household l#System
III. Methods l#of l#Calculation
Chapter l#5. l#Linear l#Ratio l#and
l#Proportion l # Chapter l#6. l#Fractional
l#Ratio l#and l#Proportion l # Chapter l#7.
l#Dimensional l#Analysis
Chapter l#8. l#Formula l#Method
IV. Administration l#of l#Medications
Chapter l#9. l#Calculating l#Oral l#Medication
l#Doses l # Chapter l#10. l#Syringes l#and
l#Needles
Chapter l#11. l#Calculating l#Parenteral l#Medication
l#Dosages l # Chapter l#12. l#Preparing l#Powdered
l#Parenteral l#Medications l # Chapter l#13.
l#Administration l#of l#Insulin
V. IV l#Therapy l#and l#Administration l#of l#Intravenous l#Medications
Chapter l#14. l#Intravenous l#Infusion l#and l#Infusion
l#Rates l # Chapter l#15. l#Calculating l#Infusion l#and
l#Completion l#Time l # Chapter l#16. l#Administering
l#IV l#Push l#Medications
VI. Verifying l#Safe l#Dose l#and l#Critical l#Care l#Calculations
Chapter l#17. l#Verifying l#Safe l#Dose
Chapter l#18. l#Titration l#of l#Intravenous l#Medications
VII. Intake l#and l#Output
Chapter l#19. l#Calculating l#Intake l#and
l#Output l # Chapter l#20. l#Calculating
l#Parenteral l#Intake
VIII. Dosages l#for l#Pediatric l#and l#Older l#Adult l#Populations
Chapter l#21. l#Considerations l#for l#the l#Pediatric
l#Patient l # Chapter l#22. l#Considerations l#for l#the
l#Older l#Adult
, Castillo/Werner-McCullough: l#Calculating l#Drug l#Dosages,
l#2e
Chapter l#1: l#Safety l#in l#Medication l#Administration
Castillo: l#Calculating l#Drug l#Dosages: l#A l#Patient-Safe l#Approach l#to l#Nursing l#and l#Math
l#2nd l#Edition
MULTIPLE l#CHOICE
1. The l#following l#medication l#order l#is l#in l#the l#patient’s l#medication l#administration
l#record l#(MAR):
methylPREDnisolone l#40 l#mg l#PO l#daily l#at l#0900.
After l#reading l#the l#order, l#the l#nurse l#correctly
l#determines: l # A “PO” l#is l#an l#inappropriate
l#abbreviation.
B the l#medication l#order l#is l#written
l#correctly. l # C 40 l#mg l#should l#be l#written
l#as l#40mg.
D tall l#man l#lettering l#indicates l#that l#the l#drug l#is l#a l#narcotic.
ANS: l#B
Feedback
The l#medication l#order l#has l#all l#the l#required l#components l#(drug l#name,
l#dose, l#route, l#and l # frequency l#of l#administration) l#for l#a l#drug l#order.
l#“PO” l#is l#an l#appropriate l#abbreviation; l # 40 l#mg l#is l#written l#correctly
l#with l#a l#space l#between l#the l#dose l#and l#the l#unit l#of l # measurement. l#Tall
l#man l#lettering l#is l#used l#to l#distinguish l#the l#drug l#from l#another l#drug
l # with l#a l#similar l#name.
2. Which l#of l#the l#following l#accurately l#describes l#the l#“Boxed l#Warning” l#found
l#on l#a l#drug l#label? l # A It l#is l#primarily l#is l#used l#to l#identify l#the l#safe l#dose
l#for l#the l#patient.
B It l#is l#commonly l#found l#on l#all l#drug l#labels.
C It l#identifies l#serious l#potential l#risks l#and l#side l#effects l#related
l#to l#drug l#use. l # D It l#protects l#the l#patient l#by l#providing
l#information l#to l#decrease l#side l#effects.
ANS: l#C
Feedback
A l#drug l#label l#with l#a l#boxed l#warning l#provides l#information l#to
l#healthcare l#professionals l # and l#patients l#regarding l#the l#serious l#risks
1
